International Biotechnology Trust plc

IBT

GB0004559349

Investment Trusts

Market Closed - London S.E. Other stock markets 11:35:11 2024-05-15 am EDT			5-day change	1st Jan Change
644 ^GBX	+1.42%		+0.31%	+0.31%

May. 08	EARNINGS: International Biotechnology bullish; Andrews Sykes profit up	AN
May. 08	Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Posts Fiscal H1 Revenue GBP650,000	MT

David Clough to Retire as Non-Executive Director of International Biotechnology Trust plc

December 09, 2015 at 11:26 am EST

International Biotechnology Trust plc announced that Dr. David Clough will retire as a non-executive Director of the company, with effect from 9 December 2015.

Latest news about International Biotechnology Trust plc

EARNINGS: International Biotechnology bullish; Andrews Sykes profit up	May. 08	AN
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Posts Fiscal H1 Revenue GBP650,000	May. 08	MT
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Posts Fiscal H1 EPS GBX72.87	May. 08	MT
International Biotechnology Trust plc Reports Earnings Results for the Half Year Ended February 29, 2024	May. 08	CI
Transcript : International Biotechnology Trust plc - Special Call	Mar. 12
International Biotechnology Trust plc commences an Equity Buyback Plan for 5,851,887 shares, representing 15.05% of its issued share capital, under the authorization approved on December 12, 2023.	Dec. 13	CI
International Biotechnology Trust plc Elects Gillian Elcock as Director	Dec. 12	CI
International Biotechnology Trust plc Declares Payment of A First Interim Dividend for the Year Ending 31 August 2023, Payable on 26 January 2024	Dec. 12	CI
International Biotechnology Trust plc Approves Dividend Policy	Dec. 12	CI
International Biotechnology Trust plc's Equity Buyback announced on March 2, 2023, has expired. with 1,881,222 shares.	Dec. 12	CI
Origin Enterprises kicks off EUR20 million buyback	Nov. 20	AN
EARNINGS: Wynnstay "optimistic" despite climate, dotdigital ups profit	Nov. 07	AN
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Posts FY23 Revenue GBP863,000	Nov. 07	MT
International Biotechnology Trust plc Reports Earnings Results for the Full Year Ended August 31, 2023	Nov. 07	CI
International Biotechnology Trust Selects Schroders as Fund Manager	23-08-03	MT
International Biotechnology Trust plc Declares the Second Interim Dividend for the Period Ending 31 August 2023, Payable on 25 August 2023	23-07-05	CI
Grafenia "cautiously optimistic" about year ahead	23-05-03	AN
Earnings Flash (IBT.L) INTL. BIOTECHNOLOGY TRUST Reports H1 EPS GBX41.57	23-05-03	MT
International Biotechnology Trust plc Reports Earnings Results for the Half Year Ended February 28, 2023	23-05-03	CI
International Biotechnology Trust plc commences an Equity Buyback Plan for 6,124,285 shares, representing 14.99% of its issued share capital, under the authorization approved on December 6, 2022.	23-03-02	CI
SV Health notifies International Biotechnology of termination in 2024	23-02-13	AN
Non-Standard drops on insolvency warning	23-02-13	AN
International Biotechnology Trust's Investment Manager to Focus on Core Healthcare Business	23-02-13	MT
TRADING UPDATES: Altona extends repayment; Kefi advances Saudi Arabia	23-02-03	AN
UK dividends calendar - next 7 days	23-01-26	AN

Chart International Biotechnology Trust plc

Duration

Period

Chart International Biotechnology Trust plc

More charts

International Biotechnology Trust plc is a United Kingdom-based investment trust company. The Companyâs investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company seeks to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialization of a product, device or enabling technology. The Companyâs investments may also be made in related sectors, such as medical devices and healthcare services. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. SV Health Managers LLP is the Company's alternative investment fund manager (AIFM).

Sector

Investment Trusts

Calendar

2024-10-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.44

Average target price

Consensus

Annual profits - Rate of surprise

Company calendar

Sector Investment Trusts

	1st Jan change	Capi.
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	+0.31%	301M
SCOTTISH MORTGAGE INVESTMENT TRUST PLC	+10.99%	14.85B
F&C INVESTMENT TRUST PLC	+9.15%	6.57B
POLAR CAPITAL TECHNOLOGY TRUST PLC	+17.53%	4.55B
ALLIANCE TRUST PLC	+13.31%	4.48B
GREENCOAT UK WIND PLC	-4.95%	4.14B
RIT CAPITAL PARTNERS PLC	+2.13%	3.51B
JPMORGAN GLOBAL GROWTH & INCOME PLC	+12.33%	3.38B
THE MONKS INVESTMENT TRUST PLC	+11.86%	3.16B
HGCAPITAL TRUST PLC	+12.89%	2.87B

Investment Trusts

International Biotechnology Trust plc

Equities

IBT

GB0004559349

Investment Trusts

David Clough to Retire as Non-Executive Director of International Biotechnology Trust plc

Latest news about International Biotechnology Trust plc

Chart International Biotechnology Trust plc

Company Profile

Income Statement Evolution

Analysts' Consensus

Annual profits - Rate of surprise

Sector Investment Trusts